PCRX Stock Chart & Stats
C$0.49
C$0.00(0.00%)
At close: 4:00 PM EDT
C$0.49
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.40 - C$0.58
Previous CloseN/A
Volume189.00K
Average Volume (3M)36.14K
Market Cap
C$96.11M
Enterprise ValueC$72.45
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Nov 26, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding196,149,930
10 Day Avg. Volume55,260
30 Day Avg. Volume36,136
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.70Price Target Upside42.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)<0.01
Revenue Forecast (FY)C$49.83M
Pharmacorp Rx Inc. News
PCRX FAQ
What was Pharmacorp Rx Inc.’s price range in the past 12 months?
Pharmacorp Rx Inc. lowest stock price was C$0.40 and its highest was C$0.58 in the past 12 months.
What is Pharmacorp Rx Inc.’s market cap?
Pharmacorp Rx Inc.’s market cap is C$96.11M.
When is Pharmacorp Rx Inc.’s upcoming earnings report date?
Pharmacorp Rx Inc.’s upcoming earnings report date is Nov 26, 2026 which is in 90 days.
How were Pharmacorp Rx Inc.’s earnings last quarter?
Pharmacorp Rx Inc. released its earnings results on Aug 20, 2026. The company reported C$0 earnings per share for the quarter, beating the consensus estimate of -C$0.003 by C$0.003.
Is Pharmacorp Rx Inc. overvalued?
According to Wall Street analysts Pharmacorp Rx Inc.’s price is currently Undervalued.
Does Pharmacorp Rx Inc. pay dividends?
Pharmacorp Rx Inc. does not currently pay dividends.
What is Pharmacorp Rx Inc.’s EPS estimate?
Pharmacorp Rx Inc.’s EPS estimate is 0.
How many shares outstanding does Pharmacorp Rx Inc. have?
Pharmacorp Rx Inc. has 196,149,930 shares outstanding.
What happened to Pharmacorp Rx Inc.’s price movement after its last earnings report?
Pharmacorp Rx Inc. reported an EPS of C$0 in its last earnings report, beating expectations of -C$0.003. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Pharmacorp Rx Inc.?
Currently, no hedge funds are holding shares in TSE:PCRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Pharmacorp Rx Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$0.70 (42.86% Upside)
C$0.70 (42.86% Upside)
Insider Transactions
Bought Shares
Worth C$388.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
81.91%
Trailing 12-Months
Company Description
Pharmacorp Rx Inc.
Proton Capital Corp is a Capital Pool Company. The principal business of the Company is to identify and evaluate assets or businesses with a view to potentially acquiring them or interest therein by completing a purchase transaction, by exercising an option, or by any concomitant transaction.
PCRX Stock 12 Month Forecast
Average Price Target
C$0.70
▲(42.86% Upside)
Technical Analysis
Reliq Health Technologies
―
Neupath Health Inc.
―
Leveljump Healthcare Corp.
―
Kovo HealthTech Corporation
―
CareSpan Health
―